Future directions for intrathecal pain management: A review and update from the interdisciplinary polyanalgesic consensus conference 2007

Timothy Deer, Elliot S. Krames, Samuel Hassenbusch, Allen Burton, David Caraway, Stuart Dupen, James Eisenach, Michael Erdek, Eric Grigsby, Phillip Kim, Robert Levy, Gladstone McDowell, Nagy Mekhail, Sunil Panchal, Joshua Prager, Richard Rauck, Michael Saulino, Todd Sitzman, Peter Staats, Michael Stanton-HicksLisa Stearns, K. Dean Willis, William Witt, Kenneth Follett, Mark Huntoon, Leong Liem, James Rathmell, Mark Wallace, Eric Buchser, Michael Cousins, Ann Ver Donck

Research output: Contribution to journalArticle

Abstract

Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use. Methods. A review of preclinical and clinical published relevant studies from 2000 to 2006 was undertaken and disseminated to a convened expert panel of physicians and nonphysicians to discuss new and novel analgesic agents for IT use. Results. The panelists identified several agents that were worthy of future studies for the clinical and rational use of IT agents that are presented in this article. Conclusions. A list of nonopioid IT analgesics, including gabapentin, adenosine, octreotide, the χ-conopeptide, Xen2174, the conopeptide, neurotensis 1 agonist, CGX-1160, the ω-conotoxin, AM-336, and physostigmine, were identified as worthy of future research by the panelists.

Original languageEnglish (US)
Pages (from-to)92-97
Number of pages6
JournalNeuromodulation
Volume11
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Pain Management
Non-Narcotic Analgesics
Physicians
Analgesics
Conotoxins
Physostigmine
Octreotide
Adenosine
Opioid Analgesics
Direction compound
Therapeutics

Keywords

  • Expert panel
  • Intrathecal
  • IT agents
  • Polyanalgesic

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neuroscience(all)

Cite this

Future directions for intrathecal pain management : A review and update from the interdisciplinary polyanalgesic consensus conference 2007. / Deer, Timothy; Krames, Elliot S.; Hassenbusch, Samuel; Burton, Allen; Caraway, David; Dupen, Stuart; Eisenach, James; Erdek, Michael; Grigsby, Eric; Kim, Phillip; Levy, Robert; McDowell, Gladstone; Mekhail, Nagy; Panchal, Sunil; Prager, Joshua; Rauck, Richard; Saulino, Michael; Sitzman, Todd; Staats, Peter; Stanton-Hicks, Michael; Stearns, Lisa; Dean Willis, K.; Witt, William; Follett, Kenneth; Huntoon, Mark; Liem, Leong; Rathmell, James; Wallace, Mark; Buchser, Eric; Cousins, Michael; Ver Donck, Ann.

In: Neuromodulation, Vol. 11, No. 2, 04.2008, p. 92-97.

Research output: Contribution to journalArticle

Deer, T, Krames, ES, Hassenbusch, S, Burton, A, Caraway, D, Dupen, S, Eisenach, J, Erdek, M, Grigsby, E, Kim, P, Levy, R, McDowell, G, Mekhail, N, Panchal, S, Prager, J, Rauck, R, Saulino, M, Sitzman, T, Staats, P, Stanton-Hicks, M, Stearns, L, Dean Willis, K, Witt, W, Follett, K, Huntoon, M, Liem, L, Rathmell, J, Wallace, M, Buchser, E, Cousins, M & Ver Donck, A 2008, 'Future directions for intrathecal pain management: A review and update from the interdisciplinary polyanalgesic consensus conference 2007', Neuromodulation, vol. 11, no. 2, pp. 92-97. https://doi.org/10.1111/j.1525-1403.2008.00148.x
Deer, Timothy ; Krames, Elliot S. ; Hassenbusch, Samuel ; Burton, Allen ; Caraway, David ; Dupen, Stuart ; Eisenach, James ; Erdek, Michael ; Grigsby, Eric ; Kim, Phillip ; Levy, Robert ; McDowell, Gladstone ; Mekhail, Nagy ; Panchal, Sunil ; Prager, Joshua ; Rauck, Richard ; Saulino, Michael ; Sitzman, Todd ; Staats, Peter ; Stanton-Hicks, Michael ; Stearns, Lisa ; Dean Willis, K. ; Witt, William ; Follett, Kenneth ; Huntoon, Mark ; Liem, Leong ; Rathmell, James ; Wallace, Mark ; Buchser, Eric ; Cousins, Michael ; Ver Donck, Ann. / Future directions for intrathecal pain management : A review and update from the interdisciplinary polyanalgesic consensus conference 2007. In: Neuromodulation. 2008 ; Vol. 11, No. 2. pp. 92-97.
@article{fd4e1594e99046608182840d32bea64d,
title = "Future directions for intrathecal pain management: A review and update from the interdisciplinary polyanalgesic consensus conference 2007",
abstract = "Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use. Methods. A review of preclinical and clinical published relevant studies from 2000 to 2006 was undertaken and disseminated to a convened expert panel of physicians and nonphysicians to discuss new and novel analgesic agents for IT use. Results. The panelists identified several agents that were worthy of future studies for the clinical and rational use of IT agents that are presented in this article. Conclusions. A list of nonopioid IT analgesics, including gabapentin, adenosine, octreotide, the χ-conopeptide, Xen2174, the conopeptide, neurotensis 1 agonist, CGX-1160, the ω-conotoxin, AM-336, and physostigmine, were identified as worthy of future research by the panelists.",
keywords = "Expert panel, Intrathecal, IT agents, Polyanalgesic",
author = "Timothy Deer and Krames, {Elliot S.} and Samuel Hassenbusch and Allen Burton and David Caraway and Stuart Dupen and James Eisenach and Michael Erdek and Eric Grigsby and Phillip Kim and Robert Levy and Gladstone McDowell and Nagy Mekhail and Sunil Panchal and Joshua Prager and Richard Rauck and Michael Saulino and Todd Sitzman and Peter Staats and Michael Stanton-Hicks and Lisa Stearns and {Dean Willis}, K. and William Witt and Kenneth Follett and Mark Huntoon and Leong Liem and James Rathmell and Mark Wallace and Eric Buchser and Michael Cousins and {Ver Donck}, Ann",
year = "2008",
month = "4",
doi = "10.1111/j.1525-1403.2008.00148.x",
language = "English (US)",
volume = "11",
pages = "92--97",
journal = "Neuromodulation",
issn = "1094-7159",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Future directions for intrathecal pain management

T2 - A review and update from the interdisciplinary polyanalgesic consensus conference 2007

AU - Deer, Timothy

AU - Krames, Elliot S.

AU - Hassenbusch, Samuel

AU - Burton, Allen

AU - Caraway, David

AU - Dupen, Stuart

AU - Eisenach, James

AU - Erdek, Michael

AU - Grigsby, Eric

AU - Kim, Phillip

AU - Levy, Robert

AU - McDowell, Gladstone

AU - Mekhail, Nagy

AU - Panchal, Sunil

AU - Prager, Joshua

AU - Rauck, Richard

AU - Saulino, Michael

AU - Sitzman, Todd

AU - Staats, Peter

AU - Stanton-Hicks, Michael

AU - Stearns, Lisa

AU - Dean Willis, K.

AU - Witt, William

AU - Follett, Kenneth

AU - Huntoon, Mark

AU - Liem, Leong

AU - Rathmell, James

AU - Wallace, Mark

AU - Buchser, Eric

AU - Cousins, Michael

AU - Ver Donck, Ann

PY - 2008/4

Y1 - 2008/4

N2 - Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use. Methods. A review of preclinical and clinical published relevant studies from 2000 to 2006 was undertaken and disseminated to a convened expert panel of physicians and nonphysicians to discuss new and novel analgesic agents for IT use. Results. The panelists identified several agents that were worthy of future studies for the clinical and rational use of IT agents that are presented in this article. Conclusions. A list of nonopioid IT analgesics, including gabapentin, adenosine, octreotide, the χ-conopeptide, Xen2174, the conopeptide, neurotensis 1 agonist, CGX-1160, the ω-conotoxin, AM-336, and physostigmine, were identified as worthy of future research by the panelists.

AB - Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use. Methods. A review of preclinical and clinical published relevant studies from 2000 to 2006 was undertaken and disseminated to a convened expert panel of physicians and nonphysicians to discuss new and novel analgesic agents for IT use. Results. The panelists identified several agents that were worthy of future studies for the clinical and rational use of IT agents that are presented in this article. Conclusions. A list of nonopioid IT analgesics, including gabapentin, adenosine, octreotide, the χ-conopeptide, Xen2174, the conopeptide, neurotensis 1 agonist, CGX-1160, the ω-conotoxin, AM-336, and physostigmine, were identified as worthy of future research by the panelists.

KW - Expert panel

KW - Intrathecal

KW - IT agents

KW - Polyanalgesic

UR - http://www.scopus.com/inward/record.url?scp=41749102879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749102879&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1403.2008.00148.x

DO - 10.1111/j.1525-1403.2008.00148.x

M3 - Article

C2 - 22151040

AN - SCOPUS:41749102879

VL - 11

SP - 92

EP - 97

JO - Neuromodulation

JF - Neuromodulation

SN - 1094-7159

IS - 2

ER -